Market Cap 5.88B
Revenue (ttm) 329.00M
Net Income (ttm) 23.38M
EPS (ttm) N/A
PE Ratio 151.71
Forward PE 40.58
Profit Margin 7.11%
Debt to Equity Ratio 1.03
Volume 2,945,000
Avg Vol 2,696,520
Day's Range N/A - N/A
Shares Out 158.76M
Stochastic %K 88%
Beta 1.94
Analysts Strong Sell
Price Target $43.50

Latest News on TGTX

TG Therapeutics: Estimates Could Soon Be Raised Again

May 28, 2025, 6:00 AM EDT - 9 days ago

TG Therapeutics: Estimates Could Soon Be Raised Again


TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:55 AM EDT - 4 weeks ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript


Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 21, 2025, 11:50 AM EDT - 2 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher


TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 3:59 PM EST - 3 months ago

TG Therapeutics: A Wonderful Hold


TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 11:55 AM EST - 3 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript


TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 21, 2025, 2:17 AM EST - 4 months ago

TG Therapeutics: 2025 Revenues Will Smash Expectations


TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 11:16 AM EST - 7 months ago

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript


TG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 3:12 PM EDT - 10 months ago

TG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call Transcript


TG Therapeutics: Less Room For Doubt About Briumvi

May 3, 2024, 9:53 AM EDT - 1 year ago

TG Therapeutics: Less Room For Doubt About Briumvi


TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript

May 2, 2024, 10:21 PM EDT - 1 year ago

TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript


TG Therapeutics stock just rallied 30%: what happened?

May 1, 2024, 9:20 AM EDT - 1 year ago

TG Therapeutics stock just rallied 30%: what happened?